FIELD: pharmacology.
SUBSTANCE: capsules for per oral introduction contain liposomes, obtained at mixing of egg lecithin and cholesterol. Liposomes contain succinic acid and 10% alcohol extract of propolis as active substances, saccharose and water purified with the following component ratio, a g per 1 capsule: succinic acid - 0.1; alcohol propolis extract 10% - 0.2; 0.2% saccharose water solution - 0.02, suspension of phosphatidylcholine and cholesterol in ratio 1:0.2 - 0.3, as auxiliary substances.
EFFECT: preparation has disintoxicating and antioxidant, as well as antiedematous, spasmolytic, anti-inflammatory, regenerating and antibacterial action, uniform release of active substances and expressed prolonged action, is convenient for independent application by patients.
3 cl, 5 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT WITH LIPOSOMES CONTAINING NICOTINIC ACID AND PROPOLIS EXTRACT HAVING DETOXIFICATION AND ANTIOXIDANT ACTIVITY | 2014 |
|
RU2585099C1 |
AGENT WITH LIPOSOMES CONTAINING GLUTAMIC ACID AND PROPOLIS EXTRACT, EXHIBITING NOOTROPIC ACTIVITY | 2015 |
|
RU2589280C1 |
AGENT WITH LIPOSOME CONTAINING ALBUMIN AND PROPOLIS EXTRACT, EXHIBITING REPARATIVE ACTIVITY IN ANAEMIAS HAEMORRHAGIC | 2015 |
|
RU2599505C1 |
AGENT WITH ISONIAZID-CONTAINING LIPOSOMES | 2016 |
|
RU2622755C1 |
CAPSULES FOR COMPLEX TREATMENT OF URINARY SYSTEM DISEASES | 2015 |
|
RU2619736C2 |
METHOD FOR PRODUCING LIPID MIXTURE AND LIPOSOMAL ORAL ANTIVIRAL THERAPEUTIC AND PROPHYLACTIC AGENT USING SAID LIPID MIXTURE | 2020 |
|
RU2746320C1 |
LIPOSOMAL AGENT BASED ON UBIQUINOL AND PREPARATION METHOD THEREOF | 2015 |
|
RU2605616C1 |
LIPOSOMAL PHARMACEUTICAL PREPARATION AND METHOD FOR PREPARING IT | 2007 |
|
RU2494729C2 |
METHOD FOR PREPARING LIPOSOMAL FORM OF BIOLOGICALLY ACTIVE SUBSTANCE | 2011 |
|
RU2477632C1 |
ANTIVIRAL MEDICINAL PREPARATION | 2003 |
|
RU2255735C2 |
Authors
Dates
2015-08-27—Published
2014-10-21—Filed